Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be an internal site version update with no changes to the study details or content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section now lists 62 sites (up from 61). It expands recruitment across multiple regions, including new U.S. states and international locations such as Canada, China, Belgium, France, Germany, Italy, Japan, the Netherlands, Spain, and the United Kingdom.SummaryDifference2%

- Check38 days agoChange DetectedNew locations were added (e.g., University Health Network in Toronto; The University of Iowa; UC Irvine Health – Chao Family Cancer Center; NEXT Virginia in San Antonio) and several locations were removed (including Wuhan, China and two London sites), with the total number of locations updated to 61.SummaryDifference1%

- Check53 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, indicating a minor system/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedRemoved the government funding lapse notice from the page; the note about potential delays and NIH operations is no longer displayed.SummaryDifference0.2%

- Check74 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.